Promising Pipeline and Strategic Collaborations Fuel Buy Rating for Silence Therapeutics
Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Silence Therapeutics (SLN – Research Report) and keeping the price ...
Business Insider14d
Keros Therapeutics: Buy Rating Affirmed Despite Setbacks, Driven by Strong Pipeline and Strategic Partnerships
Analyst Jason Zemansky of Bank of America Securities reiterated a Buy rating on Keros Therapeutics (KROS ... on the company’s promising early pipeline. The halt was influenced by the emergence ...
Yahoo Finance15d
Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain
Resolution Therapeutics, Ipsen, AstraZeneca, and others are evaluating new liver cirrhosis drugs to improve the treatment landscape. Promising pipeline liver cirrhosis therapies such as Volixibat ...
Mena FN15d
Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: Delveinsight Estimates A Diverse Pipeline Comprising 30+ Companies Working In The Domain
pipeline drug profiles, including clinical and non-clinical stage products, and the key hearing loss companies, including Acousia Therapeutics, Decibel Therapeutics, Otonomy Inc., Sensorion ...
Business Insider15d
Axsome Therapeutics: Strong Performance and Promising Pipeline Drive Buy Rating
Axsome Therapeutics (AXSM – Research Report ... Moreover, Axsome’s broader pipeline offers promising opportunities. The management is confident about advancing AXS-05 towards a filing ...
Business Insider15d
Crispr Therapeutics AG: Strategic Pipeline Progress and Financial Strength Drive Buy Rating
The in vivo gene editing pipeline is also advancing ... Additionally, Crispr Therapeutics AG plans to engage with regulators regarding B-cell malignancies and expand trials to include conditions ...
Business Insider15d
United Therapeutics: Strong Market Position and Growth Prospects with Strategic Pipeline and Capital Management
This financial strength is expected to support further growth initiatives, particularly in advancing their pipeline projects ... positions United Therapeutics well for substantial growth in ...
Mena FN16d
Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom As Over 100 Companies Leading The Charge In Research And Development Delveinsight
DelveInsight's NSCLC pipeline report depicts a robust space ... OncoResponse, Inc., Next Point Therapeutics, Inc., Light Chain Bioscience - Novimmune SA, Immunitas Therapeutics, Hansoh BioMedical ...
Le Lézard16d
Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight
Request a sample and discover the recent advances in NSCLC treatment drugs @ Non-Small Cell Lung Cancer Pipeline Report The NSCLC pipeline report provides detailed profiles of pipeline assets ...
Yahoo Finance16d
Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight
Mythic Therapeutics, Shanghai Henlius Biotech, and others are evaluating new NSCLC drugs to improve the treatment landscape. Promising NSCLC pipeline therapies such as V940, Telisotuzumab Vedotin, ...
Morningstar16d
Huntress and Forte Racing Unveil New Force at Rolex 24 at DAYTONA
COLUMBIA, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Two teams driven by speed and precision are joining forces. Huntress, known for stopping cyber threats at a record pace, is entering the high ...